• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXUSA
Device Problems Fluid/Blood Leak (1250); Leak/Splash (1354); Priming Problem (4040); Air/Gas in Device (4062)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/30/2023
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction tubing leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot l328 was conducted.There were no non-conformances associated with this lot.This lot met all release requirements.A review of kit lot l328 shows no trends.Trends were reviewed for complaint categories, alarm #48: treatment bag - air detected, tubing leak and clot observed.No trends were detected for these complaint categories.This assessment is based on the information available at the time of the investigation.At the time of this report, the analysis of the returned photographs and smart card is still in progress.A supplemental report will be filed when the analysis is complete.(b)(4).N.S.28-feb-2023.
 
Event Description
The customer contacted mallinckrodt to report they experienced a tubing leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported they received an alarm #48: treatment bag - air detected during prime, that was resolved and the treatment continued.The customer reported after the photoactivation phase of the treatment they observed air and blood clots in the treatment bag.The ecp treatment was aborted and no residual blood within the kit was returned to the patient.The customer stated they attempted to remove the recirculation pump tubing and it began to leak.The customer reported approximately 1500ml of whole blood was processed at the time the leak was observed.The customer reported the patient was in stable condition.The customer will return photographs and the smart card for evaluation.
 
Manufacturer Narrative
Photographs were provided by the customer for evaluation.The complaint kit and smart card were not returned.The smart card was not returned, therefore the reported alarm #48: treatment bag - air detected alarm could not be verified.Review of the provided photographs show the pump tubing organizer (pto) installed on the pump deck.There are no blood leaks visible on the pump deck or coming from any of the tubing.Air is visible in the tubing lines.An additional photograph shows the treatment bag component of the kit.The treatment bag is filled with air as reported by the customer.The customer report of blood clots in the treatment bag could not be verified based on the photographs provided.Section 2-9 of the cellex operators manual (1470493 rev 6) for use with software 5.4 on anticoagulant states "caution: individual patients may require a heparin dosage that varies from the recommended dose to prevent post-treatment bleeding or clotting during a treatment.The physician should review the patient's medical condition, medications and platelet count at the time of treatment and use clinical judgement to establish the optimal heparin dosage for each patient." the customer complaint was not verified based on the available information.No further action is required at this time.This investigation is now complete.(b)(4).N.S.(b)(6) 2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
blanchardstown, dublin, D15 T X2V
EI  D15 TX2V
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
mark wendelken
440 route 22 east
suite 302
bridgewater, NJ 08807
MDR Report Key16456425
MDR Text Key310532796
Report Number3013428851-2023-00009
Device Sequence Number1
Product Code LNR
UDI-Device Identifier20705030200003
UDI-Public(01)20705030200003(10)L328(17)240401
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 03/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/01/2024
Device Catalogue NumberCLXUSA
Device Lot NumberL328
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/30/2023
Initial Date FDA Received02/28/2023
Supplement Dates Manufacturer Received03/22/2023
Supplement Dates FDA Received03/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-